PapersFlow Research Brief
Pericarditis and Cardiac Tamponade
Research Guide
What is Pericarditis and Cardiac Tamponade?
Pericarditis is inflammation of the pericardium, while cardiac tamponade is a life-threatening condition caused by accumulation of fluid in the pericardial space that compresses the heart and impairs diastolic filling.
This field encompasses 35,603 papers on the diagnosis and management of pericardial diseases, including pericarditis, constrictive pericarditis, and cardiac tamponade. Key approaches involve colchicine therapy, echocardiography, and cardiac magnetic resonance imaging for evaluation and treatment. Growth data over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Acute Pericarditis Diagnosis and Management
This sub-topic covers clinical presentations, ECG criteria, biomarkers, and anti-inflammatory therapies for idiopathic and viral pericarditis. Researchers evaluate colchicine efficacy and recurrence prevention strategies.
Constrictive Pericarditis
This sub-topic examines hemodynamic features, imaging differentiation from restrictive cardiomyopathy, and pericardiectomy outcomes. Researchers study etiology progression from acute to chronic constriction.
Cardiac Tamponade Pathophysiology
This sub-topic investigates equalization of intracardiac pressures, pulsus paradoxus, and echocardiographic signs of hemodynamic compromise. Researchers model fluid dynamics and therapeutic pericardiocentesis.
Echocardiography in Pericardial Diseases
This sub-topic focuses on Doppler findings, effusion quantification, and hemodynamic assessment in pericarditis and tamponade. Researchers validate echo protocols against invasive measurements.
Cardiac Magnetic Resonance in Pericarditis
This sub-topic explores late gadolinium enhancement, pericardial thickening, and inflammation quantification in acute and recurrent cases. Researchers correlate CMR with clinical outcomes and therapy response.
Why It Matters
Guidelines from the European Society of Cardiology provide standardized protocols for diagnosing and managing pericardial diseases, aiding clinicians in distinguishing pericarditis from myocarditis and identifying tamponade through echocardiography. Adler et al. (2015) in "2015 ESC Guidelines for the diagnosis and management of pericardial diseases" recommend colchicine as first-line therapy for acute and recurrent pericarditis, reducing recurrence rates in clinical practice. Maisch et al. (2004) in "Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology" outline pericardiectomy for constrictive pericarditis, directly impacting surgical decision-making in advanced cases. Tardif et al. (2019) demonstrated in "Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction" that 0.5 mg daily colchicine lowers ischemic cardiovascular events post-myocardial infarction, with relevance to pericarditis management due to overlapping anti-inflammatory effects.
Reading Guide
Where to Start
"2015 ESC Guidelines for the diagnosis and management of pericardial diseases" by Adler et al. (2015), as it offers a comprehensive, evidence-based framework for diagnosis, therapy including colchicine, and management of tamponade suitable for initial orientation.
Key Papers Explained
Adler et al. (2015) in "2015 ESC Guidelines for the diagnosis and management of pericardial diseases" builds on Maisch et al. (2004) "Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology" by updating recommendations with new evidence on colchicine and imaging. Caforio et al. (2013) "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases" complements these by addressing differential diagnosis from myocarditis using CMR, as expanded in Friedrich et al. (2009) "Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper." Tardif et al. (2019) "Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction" provides trial data supporting colchicine's role.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current guidelines emphasize multimodality imaging with echocardiography and CMR for pericarditis and tamponade evaluation, as per Adler et al. (2015). No recent preprints or news available; focus remains on established ESC protocols for colchicine and pericardiectomy.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Current state of knowledge on aetiology, diagnosis, management... | 2013 | European Heart Journal | 3.3K | ✓ |
| 2 | Efficacy and Safety of Low-Dose Colchicine after Myocardial In... | 2019 | New England Journal of... | 2.7K | ✓ |
| 3 | 2015 ESC Guidelines for the diagnosis and management of perica... | 2015 | European Heart Journal | 2.5K | ✓ |
| 4 | Cardiovascular Magnetic Resonance in Myocarditis: A JACC White... | 2009 | Journal of the America... | 2.4K | ✓ |
| 5 | 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evalua... | 2021 | Circulation | 1.5K | ✕ |
| 6 | Guidelines on the Diagnosis and Management of Pericardial Dise... | 2004 | European Heart Journal | 1.3K | ✕ |
| 7 | Myocarditis | 2009 | New England Journal of... | 1.3K | ✕ |
| 8 | [Myocardial stunning due to simultaneous multivessel coronary ... | 1991 | PubMed | 1.2K | ✕ |
| 9 | Myocarditis | 2000 | New England Journal of... | 953 | ✕ |
| 10 | Update on Myocarditis | 2012 | Journal of the America... | 867 | ✕ |
Frequently Asked Questions
What are the ESC recommendations for pericarditis management?
The 2015 ESC Guidelines recommend colchicine combined with aspirin or NSAIDs as first-line therapy for acute pericarditis to reduce symptoms and recurrence. Adler et al. (2015) emphasize echocardiography for detecting effusion and tamponade. Pericardiectomy is advised for chronic constrictive pericarditis unresponsive to medical therapy.
How is cardiac tamponade diagnosed?
Cardiac tamponade is diagnosed by clinical signs of hemodynamic compromise plus echocardiographic evidence of pericardial effusion with right atrial or ventricular collapse. The 2015 ESC Guidelines highlight urgent pericardiocentesis as treatment. Maisch et al. (2004) stress multimodal imaging including echocardiography for confirmation.
What role does colchicine play in pericarditis?
Colchicine reduces inflammation and recurrence in acute, recurrent, and post-pericardiotomy pericarditis. Adler et al. (2015) recommend low-dose colchicine for 3 months in acute cases. Tardif et al. (2019) confirmed its safety and efficacy at 0.5 mg daily in cardiovascular patients.
What distinguishes pericarditis from myocarditis?
Pericarditis primarily affects the pericardium with chest pain and effusion, while myocarditis involves myocardial inflammation leading to ventricular dysfunction. Caforio et al. (2013) in "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases" propose diagnostic criteria using CMR and biopsy to differentiate. Friedrich et al. (2009) detail CMR patterns for myocarditis.
When is pericardiectomy indicated?
Pericardiectomy is indicated for symptomatic constrictive pericarditis after failed medical therapy. Maisch et al. (2004) guidelines recommend it for persistent constriction. Adler et al. (2015) note imaging confirmation via echocardiography or CMR.
Open Research Questions
- ? What are optimal diagnostic criteria to differentiate acute pericarditis from myocarditis in patients with overlapping echocardiographic findings?
- ? How can imaging modalities like CMR improve early detection of progression from pericarditis to tamponade?
- ? What long-term outcomes follow colchicine therapy in recurrent pericarditis compared to NSAIDs alone?
- ? Which patients with constrictive pericarditis benefit most from pericardiectomy versus conservative management?
Recent Trends
The field includes 35,603 works with no specified 5-year growth rate.
Tardif et al. "Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction" (2727 citations) reinforced colchicine's cardiovascular benefits at 0.5 mg daily.
2019No recent preprints or news reported.
Research Pericarditis and Cardiac Tamponade with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pericarditis and Cardiac Tamponade with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers